Regeneron Pharmaceuticals, Inc.

Holdings as of Sep 30, 2026 · filed Nov 5, 2026

$179631814
Portfolio value
3
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Parabilis Medicines, Inc. $134541645 74.90% — Held
2 Intellia Therapeutics, Inc. $44658120 24.86% — Held
3 Adicet Bio, Inc. $432049 0.24% — Held

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.